glp-1 agonists reduce inflammation drugs calm beyond diabetes and weight loss Taming the fires
Description
Download Summary Sheet Here
Many patients lost 1520% or more over 68 weeks
long-term outcomes are being studied
Sold under brand names like Ozempic, Saxenda, and Rybelsus, glucagon-like peptide-1 receptor agonists have been called Hollywoods new secret and TikToks favorite weight loss drug. Pharma industry observers say this class of medication has officially reached blockbuster status
The theoretical benefits of low-dose GLP-1 therapy for inflammation include the potential for anti-inflammatory effects with a reduced side effect burden compared to standard doses
134979-01-4, CH2COOH-PEG2-NH2.HCl References: [1] Tan, Q., Akindehin, S
